Peter Schafer
122Patents
15h-index
104Co-inventors
89Inventor score
Filing activity: Feb 15, 1996 → Sep 30, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8715677B2 | Immunological uses of immunomodulatory compounds for vaccine and anti-infectious disease therapy | Emerging Cross-Sectional Technologies | 48 | Active |
| US6962940B2 | (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof | Emerging Cross-Sectional Technologies | 43 | Expired |
| US7427638B2 | (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione:, and methods of synthesis and compositions thereof | Emerging Cross-Sectional Technologies | 34 | Active |
| US7893101B2 | Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof | Chemistry; Metallurgy | 29 | Active |
| US7208516B2 | Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione | Human Necessities | 27 | Expired |
| US7659302B2 | Methods of using (+)-2-[1-(3-ethoxy-4 methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione | Emerging Cross-Sectional Technologies | 24 | Active |
| US6455515B2 | Salicylohydrazide derivatives, processes and intermediates for their preparation, compositions comprising them, and their use | Chemistry; Metallurgy | 23 | Expired |
| US8455536B2 | Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione | Emerging Cross-Sectional Technologies | 20 | Active |
| US7276529B2 | Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione | Chemistry; Metallurgy | 20 | Expired |
| US6191280A | Method for producing substituted thiopyridines | Chemistry; Metallurgy | 18 | Expired |
| US7358272B2 | Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione | Emerging Cross-Sectional Technologies | 18 | Active |
| US7507759B2 | Methods of using(+)-2-[1-(3-ethoxy-4methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3,-dione | Emerging Cross-Sectional Technologies | 17 | Active |
| US6362380B1 | Preparation of nitrobiphenyls | Chemistry; Metallurgy | 17 | Expired |
| US10047151B2 | Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor | Physics | 16 | Active |
| US6624119B1 | 3-[Benz(ox/thi)azol-7-yl]-1h-pyrimidine-2,4-diones | Chemistry; Metallurgy | 15 | Expired |
| US7659303B2 | Methods of using (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4- acetylaminoisoindoline-1,3-dione | Emerging Cross-Sectional Technologies | 15 | Active |
| US8093283B2 | Solid forms comprising (+)-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisinoline-1,3-dione, compositions thereof, and uses thereof | Chemistry; Metallurgy | 13 | Active |
| US9365640B2 | Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor | Physics | 12 | Active |
| US8906932B2 | Methods of treating cancer using 3-(5-amino-2-methyl-4-oxo-4Hquinazolin-3-yl)-piperidine-2,6-dione | Human Necessities | 11 | Active |
| US8629173B2 | Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof | Chemistry; Metallurgy | 10 | Active |
| US8802717B2 | Methods of treating arthritic conditions using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione | Emerging Cross-Sectional Technologies | 9 | Active |
| US10751414B2 | Methods of treating psoriasis using PD-1 binding antibodies | Chemistry; Metallurgy | 8 | Active |
| US9018243B2 | Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof | Chemistry; Metallurgy | 8 | Active |
| US9857359B2 | Methods for determining drug efficacy using cereblon-associated proteins | Physics | 7 | Active |
| US9283207B2 | Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione | Emerging Cross-Sectional Technologies | 6 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.